Literature DB >> 4372891

Experimental cytomegalovirus ophthalmitis.

J N Schwartz, C A Daniels, J C Shivers, G K Klintworth.   

Abstract

Cytomegalovirus can produce a severe necrotizing chorioretinitis in patients on immunosuppressive therapy and infants born with congenital cytomegaloviral inclusion disease. To study the effect of cytomegalovirus on the eye, murine cytomegalovirus was injected into the eyes of nonimmunosuppressed Swiss CD-1 weanling mice. The eyes were then prepared for virus titer, as well as light and electron microscopy at variable periods after inoculation (1 to 28 days). From days 2 to 6, the hallmarks of cytomegalovirus infection, intranuclear and intracytoplasmic viral inclusions, were evident within cytomegalic cells. The major site of reaction was in the uveal tract, where necrosis and inflammation were prominent. Viral particles budding through the nuclear membranes into the perinuclear cisternae and vacuoles with viral particles could be seen in the cytoplasm of infected cells. In lesions older than 2 weeks, only a mild mixed inflammatory infiltrate and fibrosis were observed. Morphologic alterations unaccompanied by inflammation occurred in the outer sensory retina overlying infected retinal pigment epithelial cells. Multiple necrotic foci with inclusion-bearing cells in the liver indicated the systemic spread of virus from the eye. The titer of virus recovered from the eye peaked at day 4 and then declined to low levels, but infectious virus could still be isolated at day 28, even though viral particles were not seen morphologically at or after day 14. Many of the alterations seen in the model resemble those found in the human cytomegaloviral ophthalmitis.

Entities:  

Mesh:

Year:  1974        PMID: 4372891      PMCID: PMC1910938     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  OPHTHALMIC LESIONS DUE TO CYTOMEGALIC INCLUSION DISEASE.

Authors:  G MIKLOS; T ORBAN
Journal:  Ophthalmologica       Date:  1964       Impact factor: 3.250

2.  A PLAQUE REDUCTION NEUTRALIZATION TEST FOR HUMAN CYTOMEGALOVIRUS.

Authors:  G PLUMMER; M BENYESH-MELNICK
Journal:  Proc Soc Exp Biol Med       Date:  1964-10

3.  Cytomegalic inclusion disease: report of a case.

Authors:  G DVORAK-THEOBALD
Journal:  Am J Ophthalmol       Date:  1959-05       Impact factor: 5.258

4.  Cytomegalic inclusion disease.

Authors:  A ALLEN; H W BEEMAN; L CHRISTENSEN
Journal:  AMA Arch Ophthalmol       Date:  1957-01

5.  Monolayer tissue cultures. I. Preparation and standardization of suspensions of trypsin-dispersed monkey kidney cells.

Authors:  J S YOUNGNER
Journal:  Proc Soc Exp Biol Med       Date:  1954-02

6.  Adult cytomegalic inclusion retinitis.

Authors:  G J Wyhinny; D J Apple; F R Guastella; C M Vygantas
Journal:  Am J Ophthalmol       Date:  1973-11       Impact factor: 5.258

7.  Cytomegalic inclusion retinitis in an adult.

Authors:  G De Venecia; G M Zu Rhein; M V Pratt; W Kisken
Journal:  Arch Ophthalmol       Date:  1971-07

8.  Ocular involvement in congenital cytomegalic inclusion disease.

Authors:  M E Smith; L E Zimmerman; R D Harley
Journal:  Arch Ophthalmol       Date:  1966-11

9.  Mouse cytomegalovirus. Necrosis of infected and morphologically normal submaxillary gland acinar cells during termination of chronic infection.

Authors:  D Henson; A J Strano
Journal:  Am J Pathol       Date:  1972-07       Impact factor: 4.307

10.  C3 leukotactic factors produced by a tissue protease.

Authors:  J H Hill; P A Ward
Journal:  J Exp Med       Date:  1969-09-01       Impact factor: 14.307

View more
  9 in total

1.  Lymphoid cell necrosis, thymic atrophy, and growth retardation in newborn mice inoculated with murine cytomegalovirus.

Authors:  J N Schwartz; C A Daniels; G K Klintworth
Journal:  Am J Pathol       Date:  1975-06       Impact factor: 4.307

Review 2.  The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.

Authors:  J B Hudson
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

Review 3.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

4.  Age-related neurocytotropism of mouse cytomegalovirus in explanted trigeminal ganglions.

Authors:  G L Davis; K W Krawczyk; M M Hawrisiak
Journal:  Am J Pathol       Date:  1979-11       Impact factor: 4.307

5.  Anti-dermatitic effect of fermented ginseng extract including rich compound K through inhibiting activation of macrophage.

Authors:  Ji Yeon Lee; Jae-Myung Yoo; Seong Yeon Baek; Mee Ree Kim
Journal:  Food Sci Biotechnol       Date:  2019-06-07       Impact factor: 2.391

6.  Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS).

Authors:  A H Friedman; J Orellana; W R Freeman; M H Luntz; M B Starr; M L Tapper; I Spigland; H Roterdam; R Mesa Tejada; S Braunhut; D Mildvan; U Mathur
Journal:  Br J Ophthalmol       Date:  1983-06       Impact factor: 4.638

7.  Mulberry Fruit Prevents Diabetes and Diabetic Dementia by Regulation of Blood Glucose through Upregulation of Antioxidative Activities and CREB/BDNF Pathway in Alloxan-Induced Diabetic Mice.

Authors:  A Young Min; Jae-Myung Yoo; Dai-Eun Sok; Mee Ree Kim
Journal:  Oxid Med Cell Longev       Date:  2020-05-04       Impact factor: 6.543

8.  Cytomegalovirus replication and the host immune response.

Authors:  D J Lang; K S Cheung; J N Schwartz; C A Daniels; S E Harwood
Journal:  Yale J Biol Med       Date:  1976-03

9.  3,3'-Diindolylmethane Promotes BDNF and Antioxidant Enzyme Formation via TrkB/Akt Pathway Activation for Neuroprotection against Oxidative Stress-Induced Apoptosis in Hippocampal Neuronal Cells.

Authors:  Bo Dam Lee; Jae-Myung Yoo; Seong Yeon Baek; Fu Yi Li; Dai-Eun Sok; Mee Ree Kim
Journal:  Antioxidants (Basel)       Date:  2019-12-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.